Coeptis Therapeutics Holdings Inc. Common Stock (COEP) is a publicly traded Healthcare sector company. As of May 21, 2026, COEP trades at $16.40 with a market cap of $102.06M and a P/E ratio of -6.51. COEP moved +1.05% today. Year to date, COEP is +6.49%; over the trailing twelve months it is +31.52%. Its 52-week range spans $2.31 to $21.41. Analyst consensus is buy with an average price target of $0.00. Rallies surfaces COEP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Coeptis Therapeutics Holdings Inc. Common Stock (COEP) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. COEP moved +1.05% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $16.40 |
| Market Cap | $102.06M |
| P/E Ratio | -6.51 |
| EPS | $-2.52 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.41 |
| 52-Week Low | $2.31 |
| Volume | 111.93K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.41M |
| Net Income | $-12.93M |
| Gross Margin | 87.22% |
1 analysts cover COEP: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $0.00.